Steven M Blum

6PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Natural language processingPredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events.

Steven M Blum, Ben Ouyang, Leyre Zubiri

|Sep 03, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic

|Nov 24, 2023
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.

Sujin Hyung, Jihoon Ko, You Jeong Heo

|Aug 14, 2023
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.

Steven M Blum, Sherin J Rouhani, Ryan J Sullivan

|Sep 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.

Leyre Zubiri, Gabriel E Molina, Meghan J Mooradian

|Mar 15, 2019
"Inactive" ingredients in oral medications.

Daniel Reker, Steven M Blum, Christoph Steiger

Pageof 1

Frequent Collaborators

3 joint publications

Leyre Zubiri

3 joint publications

Michael Dougan

2 joint publications

Meghan J Mooradian

2 joint publications

Ryan J Sullivan